Highlights
- Wesfarmers (ASX:WES) presented its 2026 annual meeting addresses on 29 October, following the August full-year results.
- The October annual meeting places Bunnings, Kmart Group and Officeworks alongside the group’s healthcare and industrial operations.
- Retail requirements vary.
- FY26 Revenue reached AUD 47.274 billion, while statutory net profit was AUD 2.874 billion.
Wesfarmers (ASX:WES) operates retail, healthcare, chemicals and industrial businesses across Australia and New Zealand. On 20 November 2026, its shares were quoted at AUD 76.44, down 1.38% during the session. The October AGM and FY26 results focus on the current retail divisions, healthcare operations and lithium investment.
The October 2026 annual meeting followed full-year reporting on retail operations, healthcare and the group’s industrial investments.
FY26 operating priorities and the October AGM
For the year ended 30 June 2026, revenue increased 3.4% to AUD 47.274 billion. Statutory net profit after tax was AUD 2.874 billion, compared with AUD 2.926 billion in FY25. Excluding significant items in the prior year, profit rose 8.3%. Operating Cash Flow declined to AUD 4.272 billion from AUD 4.568 billion, while free cash flow increased to AUD 3.992 billion.
These figures describe the combined portfolio rather than any single chain. Retail demand, purchasing costs and inventory requirements influence the consumer businesses, while chemical pricing, production rates and commissioning schedules affect industrial operations.
Retail Division Performance and Reporting
Bunnings sells home-improvement and trade-related products through warehouses and other retail channels. Its results are sensitive to sales activity, gross margins, merchandise availability, staffing and operating expenditure. Financial assessment should consider retail volumes and returns on invested Capital rather than treating all household purchases as interchangeable.
Kmart Group and Officeworks serve different retail categories, with variations in product sourcing, seasonal Demand and customer spending. The group’s 2026 reporting provides separate divisional results, allowing operating trends to be considered against each business’s respective costs and capital requirements.
Healthcare, Lithium and the Current Business Mix
The group’s healthcare interests combine pharmaceutical distribution and consumer-facing retail activity. Performance measures include sales, supply-chain reliability, inventory management and distribution efficiency. The lithium venture presents a different set of reporting priorities involving production capability, Capital Expenditure and Commodity conditions.
The company’s current Operating Activities include Bunnings home improvement, Kmart Group general merchandise, Officeworks office and technology products, healthcare and pharmaceutical distribution, and Wesfarmers Chemicals, Energy and Fertilisers.
Retail Trading and Resource Project Execution
The October annual meeting places Bunnings, Kmart Group and Officeworks alongside the group’s healthcare and industrial operations. Their operating characteristics differ: home improvement depends on trade and household activity, while discount department stores manage seasonal merchandise and discretionary demand. Divisional reporting is therefore more informative than assuming a single retail demand pattern applies to the portfolio.
Healthcare distribution and Retailing introduce product availability, pharmacy service and logistics considerations. The lithium Investment adds commissioning, capital allocation and commodity exposure. Updates on each activity should be assessed against the relevant division’s disclosed capital expenditure, Earnings and operating cash flow, without attributing performance across unrelated businesses.
Risks to Consider
The group faces retail competition, variable household demand, labour and supply-chain costs, and exposure to chemicals and lithium markets. Acquisitions, store systems, logistics projects and industrial expansions also require integration spending and operational execution.
What to Watch Next
Future disclosures can show how established chains perform alongside newer healthcare Assets and the lithium venture. Relevant measures include divisional earnings, operating cash flow, capital expenditure and progress on Manufacturing and distribution projects. Changes in portfolio composition remain material to understanding longer-term results.
Key Insights
The October AGM and FY26 results frame current priorities across retailing, healthcare and industrial investment. The group reported AUD 47.274 billion in FY26 revenue and AUD 2.874 billion in statutory net profit. Divisional trading, cash flows and lithium project execution remain distinct monitoring points.






Please wait processing your request...